STAU1

Across TCGA pan-cancer cohorts, STAU1 mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated STAU1 data layer compared with 27 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher STAU1 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated STAU1 expression acts as an unfavorable survival marker, although some lineages such as COAD and LUAD show a favorable association.

COAD, CCRCC, and LSCC are the cancer types where STAU1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	All	1.000	0.918	.012	42	view →
CCRCC	DFS	Quartile	III,IV	0.331	0.831	.002	34	view →
LSCC	OS	Median	III,IV	0.723	1.000	.003	16	view →
LUAD	OS	Median	II,III,IV	1.000	0.807	.010	14	view →
PDAC	DFS	Median	IV	0.214	0.785	.006	12	view →
UCEC	OS	Median	All	0.863	1.000	.033	2	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

STAU1–COAD (DFS)

Open the COAD breakdown →